ALTERATIONS IN P53 AND P16(INK4) EXPRESSION AND TELOMERE LENGTH DURING SPONTANEOUS IMMORTALIZATION OF LI-FRAUMENI SYNDROME FIBROBLASTS

被引:0
|
作者
ROGAN, EM
BRYAN, TM
HUKKU, B
MACLEAN, K
CHANG, ACM
MOY, EL
ENGLEZOU, A
WARNEFORD, SG
DALLAPOZZA, L
REDDEL, RR
机构
[1] CHILDRENS MED RES INST,CANC RES GRP,SYDNEY,NSW 2145,AUSTRALIA
[2] ROYAL ALEXANDRA HOSP CHILDREN,CAMPERDOWN,NSW 2050,AUSTRALIA
[3] CHILDRENS HOSP MICHIGAN,CELL CULTURE LAB,DETROIT,MI 48201
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Normal cells have a strictly limited growth potential and senesce after a defined number of population doublings (PDs), In contrast, tumor cells often exhibit an apparently unlimited proliferative potential and are termed immortalized, Although spontaneous immortalization of normal human cells in vitro is an extremely rare event, we observed this in fibroblasts from an affected member of a Li-Fraumeni syndrome kindred, The fibroblasts were heterozygous for a p53 mutation and underwent senescence as expected at PD 40, In four separate senescent cultures (A to D), there were cells that eventually recommenced proliferation, This was associated with aneuploidy in all four cultures and either loss (cultures A, C, and D) or mutation (culture B) of the wild-type (wt) p53 allele. Loss of wt p53 function was insufficient for immortalization, since cultures A, B, and D subsequently entered crisis from which they did not escape. Culture C has continued proliferating beyond 400 PDs and thus appears to be immortalized, In contrast to the other cultures, the immortalized cells have no detectable p16(INK4) protein, A culture that had a limited extension of proliferative potential exhibited a progressive decrease in telomere length with increasing PD. In the culture that subsequently became immortalized, the same trend occurred until PD 73, after which there was a significant increase in the amount of telomeric DNA, despite the absence of telomerase activity, Immortalization of these cells thus appears to be associated with loss of wt p53 and p16(INK4) expression and a novel mechanism for the elongation of telomeres.
引用
收藏
页码:4745 / 4753
页数:9
相关论文
共 50 条
  • [21] Investigating the interaction between the microbiome and mutant p53 in Li-Fraumeni Syndrome
    Ong, Noel Wei
    Giovino, Camilla Maria
    Fischer, Nicholas William
    Psarianos, Pamela
    Malkin, David
    CANCER RESEARCH, 2022, 82 (12)
  • [22] p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome
    Susan Quesnel
    Sigitas Verselis
    Carol Portwine
    Judy Garber
    Marga White
    Jean Feunteun
    David Malkin
    Frederick P Li
    Oncogene, 1999, 18 : 3970 - 3978
  • [23] p16(INK4) and p15(INK4B) alterations in primary gynecologic malignancy
    Wong, YF
    Chung, TKH
    Cheung, TH
    Nobori, T
    Yim, SF
    Lai, KWH
    Yu, AL
    Diccianni, MB
    Li, TZ
    Chang, AMZ
    GYNECOLOGIC ONCOLOGY, 1997, 65 (02) : 319 - 324
  • [24] MUTATIONS AND ALTERED EXPRESSION OF P16(INK4) IN HUMAN CANCER
    OKAMOTO, A
    DEMETRICK, DJ
    SPILLARE, EA
    HAGIWARA, K
    HUSSAIN, SP
    BENNETT, WP
    FORRESTER, K
    GERWIN, B
    SERRANO, M
    BEACH, DH
    HARRIS, CC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) : 11045 - 11049
  • [25] Genetic alterations of p16(INK4a) and p53 genes in sporadic dysplastic nevus
    Lee, JY
    Dong, SM
    Shin, MS
    Kim, SY
    Lee, SH
    Kang, SJ
    Lee, JD
    Kim, CS
    Kim, SH
    Yoo, NJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 667 - 672
  • [26] Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice -: A model for Li-Fraumeni syndrome
    Kuperwasser, C
    Hurlbut, GD
    Kittrell, FS
    Dickinson, ES
    Laucirica, R
    Medina, D
    Naber, SP
    Jerry, DJ
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (06): : 2151 - 2159
  • [27] Novel p53 splice site mutations in three families with Li-Fraumeni syndrome
    Sigitas J Verselis
    James G Rheinwald
    Joseph F Fraumeni
    Frederick P Li
    Oncogene, 2000, 19 : 4230 - 4235
  • [28] Beyond Li-Fraumeni syndrome: Clinical characteristics of families with p53 germline mutations
    Gonzalez, K. D.
    Noltner, K. A.
    Buzin, C. H.
    Gu, D.
    Wen-Fong, C. Y.
    Ngyuen, V. Q.
    Han, J. H.
    Lowstuter, K.
    Longmate, J.
    Sommer, S. S.
    Weitzel, J. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome
    Fischer, Nicholas W.
    Prodeus, Aaron
    Tran, James
    Malkin, David
    Gariepy, Jean
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (12): : 1418 - 1421
  • [30] Li-Fraumeni syndrome and the role of the p53 tumor suppressor gene in cancer susceptibility
    Akashi, M
    Koeffler, HP
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1998, 41 (01): : 172 - 199